Darren Carpizo, Scientific Founder
Dr. Carpizo earned his medical degree from the University of Illinois at Chicago. He completed a residency in Surgery and a PhD in Molecular, Cell and Developmental Biology at University of California Los Angeles Medical Center and a fellowship in surgical oncology at Memorial Sloan-Kettering Cancer Institute, New York.
S. David Kimball, Scientific Founder
Dr. Kimball is currently Associate Vice President of Rutgers Translational Sciences and Research Commercialization, in the Office of Research and Economic Development. He is also a Research Professor in the Ernest Mario School of Pharmacy. David obtained his PhD in Organic Chemistry/Chemical Biology from the State University of New York at Stony Brook and spent the first 19 years of his career at Bristol-Myers Squibb Pharmaceutical Research Institute, leading drug discovery and development efforts in cardiovascular medicine and oncology.
In 2001 he moved to Lexicon Pharmaceuticals in Princeton, NJ, as Vice President of Chemistry and directed the discovery and development chemistry efforts for Lexicon's entire small molecule clinical pipeline. Prior to joining Rutgers University, David also served as Senior Vice President of Nonclinical Research at Pharma-copeia, Inc., and Chief Scientific Officer of Hydra Biosciences, in Cambridge, MA.